Individualized Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation
Clinical trial NCT04778618 · UNKNOWN
Trial details
- NCT number
- NCT04778618
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2022-07-31
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.